首页> 外国专利> Pharmaceutical composition made of microparticles for controlled release of triptorelin and use thereof for the manufacture of a drug for the treatment of prostate cancer

Pharmaceutical composition made of microparticles for controlled release of triptorelin and use thereof for the manufacture of a drug for the treatment of prostate cancer

机译:用于控制曲普瑞林的由微粒制成的药物组合物及其在制备用于治疗前列腺癌的药物中的用途

摘要

Pharmaceutical composition made of microparticles for the slow release of an active substance at least during a period covering the 6 th month after injection of said composition, said composition comprising a group of microparticles made of a copolymer of the PLGA type which incorporate an active substance in the form of a water insoluble peptide sa said copolymer furthermore comprising at least 75 % of lactic acid and an inherent viscosity between 0.1 and 0.9 dl/g, as measured in chloroform at 25°C and at a polymer concentration of 0.5 g/dL; said microparticles furthermore having a size distribution defined as follows : - D (v,0.1) is between 10 and 30 micrometers, - D (v,0.5) is between 30 and 70 micrometers, - D(v,0.9) is between 50 and 110 micrometers.
机译:由微粒制成的药物组合物,其至少在注射所述组合物后的第6个月的期间内缓慢释放活性物质,所述组合物包含一组由PLGA型共聚物制成的微粒,所述微粒在其中掺入了活性物质水不溶性肽盐的形式;所述共聚物还包含至少75%的乳酸和0.1至0.9dl / g的比浓对数粘度,在25℃的氯仿中和0.5g / dL的聚合物浓度下测得。所述微粒还具有如下定义的尺寸分布:-D(v,0.1)在10到30微米之间,-D(v,0.5)在30到70微米之间,-D(v,0.9)在50到110微米之间。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号